Sponsor study identifier
interventional
80
1 country
1
Study Start
September 29, 2024
Actual (reported)Primary Completion
April 30, 2025
Actual (reported)Study Completion
December 30, 2025
Actual (reported)The goal of this study is to evaluate the comparative effectiveness of CT-guided and fluoroscopic-guided genicular nerve ablation in reducing knee pain and improving function in adults diagnosed with knee osteoarthritis refractory to conservative treatment. The main questions it aims to answer are:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 30, 2025
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 17, 2024
Actual (reported)July 23, 2024
Actual (reported)September 29, 2024
Actual (reported)April 30, 2025
Actual (reported)December 30, 2025
Actual (reported)Reduction in Knee Pain
This measure assesses the change in knee pain as reported by participants using the Visual Analog Scale (VAS). A lower score indicates less pain, signifying an improvement.
3 months post-procedure
Improvement in Knee Function
Assessed at baseline, 1 month, 3 months, and 6 months post-procedure
Incidence of Procedure-Related Adverse Events
From the time of procedure up to 6 months
Patient Satisfaction with the Procedure
3 months post-procedure
Participants in this arm will undergo genicular nerve ablation using computed tomography (CT) guidance. The procedure involves precise needle placement based on CT imaging to effectively target the genicular nerves responsible for transmitting pain signals from the knee.
Participants in this arm will receive genicular nerve ablation using fluoroscopic guidance. The procedure utilizes real-time fluoroscopy to guide needle placement for the ablation of the genicular nerves.
This procedure involves using computed tomography (CT) imaging to guide the precise placement of a needle for the ablation of genicular nerves in the knee. The goal is to disrupt the pain signals caused by osteoarthritis, providing long-term pain relief. The intervention is performed under local anesthesia and is aimed at patients who have not responded adequately to conservative pain management strategies.
Zagazig University, Faculty of Medicine
Zagazig, Sharqia Province, 44519, Egypt
Ahmed A Bessar, MD, PhD
Assistant Professor of Diagnostic and Interventional Radiology, Zagazig Uni.
80 participants (actual enrollment reported by the registry).
First Submitted
July 17, 2024
This procedure utilizes fluoroscopy to accurately guide the needle placement for the ablation of genicular nerves associated with osteoarthritis knee pain. The technique focuses on minimizing pain and improving functional mobility by disrupting nerve pathways that transmit pain signals. Like the CT-guided approach, it is intended for use in patients whose symptoms have not been sufficiently managed with non-invasive treatments.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
First Posted
July 23, 2024
Study Start
September 29, 2024
Actual (reported)Primary Completion
April 30, 2025
Actual (reported)Study Completion
December 30, 2025
Actual (reported)Last Updated
September 23, 2026
Record last verified: 2026-09
At this time, there is no plan to share individual participant data (IPD) with other researchers. This decision is based on considerations related to patient confidentiality, data privacy concerns, and the absence of a current infrastructure for secure data sharing. The primary results of the study will be published in peer-reviewed journals and presented at scientific conferences, ensuring that the findings are accessible to the broader research community.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: